Table 3.
Testing human sera for PCMV and HCMV by Western blot analysis.
| Number | Serum Number | HCMV IgG (1) | Western Blot Analysis Using PCMV gB Antigens (2) | |
|---|---|---|---|---|
| R1 | R2 | |||
| 1 | 914,640 | − | − | + |
| 2 (3) | 914,644 | − | − | − |
| 3 (3) | 914,672 | + | − | + |
| 4 | 914,714 | − | − | + |
| 5 | 914,814 | + | − | − |
| 6 | 914,854 | − | + | |
| 7 | 914,855 | + | − | − |
| 8 | 914,887 | − | − | + |
| 9 | 914,978 | + | − | − |
| 10 | 914,984 | + | − | − |
| 11 (3) | 914,986 | + | − | + |
| 12 | 914,998 | + | − | − |
| 13 | 915,159 | + | − | − |
| 14 (3) | 915,164 | + | − | + |
| 15 | 915,274 | + | − | − |
(1) Using the LIAISON CMV IgG II assay; (2) All sera were diluted 1:150; (3) Gray: identical result in PCMV (R2) and HCMV testing.